Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free TAK Stock Alerts $13.38 +0.32 (+2.45%) (As of 05/9/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateFeb. 1ConfirmedActual EPS (Feb. 1) $0.51 Beat By $0.51 Get Takeda Pharmaceutical Earnings AlertsEnter your email address below to receive the latest news and earnings results for TAK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTAK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TAK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. Takeda Pharmaceutical Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$1.50 EPSNext Year EPS Consensus Estimate: $1.55 EPSTAK Earnings Date and InformationTakeda Pharmaceutical last issued its quarterly earnings data on February 1st, 2024. The reported $0.51 EPS for the quarter. The firm earned $7.52 billion during the quarter. Takeda Pharmaceutical has generated $0.66 earnings per share over the last year ($0.66 diluted earnings per share) and currently has a price-to-earnings ratio of 20.3. Earnings for Takeda Pharmaceutical are expected to grow by 3.33% in the coming year, from $1.50 to $1.55 per share. Read More Takeda Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/1/2024Q3 2024-$0.51+$0.51$0.79-$7.52 billion10/26/2023Q2 2024-$0.50+$0.50$0.86-$6.94 billion7/27/2023Q1 2024-$0.55+$0.55$0.89-$7.71 billion5/11/2023Q4 2023-$0.39+$0.39$0.70-$7.23 billion2/2/2023Q3 2023-$0.46+$0.46$0.63-$8.40 billion10/27/2022Q2 2023-$0.52+$0.52$0.90-$7.26 billion Get the Latest News and Ratings for TAK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 7/28/2022Q1 2023-$0.56+$0.56$0.86-$7.51 billion5/11/2022Q4 2022-$0.38+$0.38$0.79-$7.19 billion2/3/2022Q3 2022-$0.54+$0.54$0.91-$8.21 billion 10/28/2021Q2 2022-$0.45+$0.45$0.77-$7.67 billion7/30/2021Q1 2022-$0.51+$0.51$0.44-$8.68 billion 5/11/2021Q4 2021-$0.41+$0.41$0.23-$7.27 billion Takeda Pharmaceutical Earnings - Frequently Asked Questions When did Takeda Pharmaceutical announce their last quarterly earnings? Takeda Pharmaceutical (NYSE:TAK) last announced its quarterly earning data on Thursday, February 1, 2024. Learn more on TAK's earnings history. How much revenue does Takeda Pharmaceutical generate each year? Takeda Pharmaceutical (NYSE:TAK) has a recorded annual revenue of $29.81 billion. How much profit does Takeda Pharmaceutical generate each year? Takeda Pharmaceutical (NYSE:TAK) has a recorded net income of $2.35 billion. TAK has generated $0.66 earnings per share over the last four quarters. What is Takeda Pharmaceutical's price-to-earnings ratio? Takeda Pharmaceutical (NYSE:TAK) has a trailing price-to-earnings ratio of 20.27 and a forward price-to-earnings ratio of 8.92. The price/earnings-to-growth ratio is 3.05. What is Takeda Pharmaceutical's EPS forecast for next year? Takeda Pharmaceutical's earnings are expected to grow from $1.50 per share to $1.55 per share in the next year, which is a 3.33% increase. More Earnings Resources from MarketBeat Related Companies: Genmab A/S Earnings Results Alnylam Pharmaceuticals Earnings Results Teva Pharmaceutical Industries Earnings Results BioMarin Pharmaceutical Earnings Results BeiGene Earnings Results Viatris Earnings Results Karuna Therapeutics Earnings Results Dr. Reddy's Laboratories Earnings Results Sarepta Therapeutics Earnings Results United Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NYSE:TAK) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
